Vimarsana
Biggest News Aggregation in the World

Abbott Vascular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abbott Vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abbott Vascular Today - Breaking & Trending Today

Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO - Vimarsana News

Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO

/PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure by a...

Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member - Vimarsana News

Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member

WOBURN, Mass., March 25, 2024 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the appointment of Matt Schmidt as chief executive officer and board of directors member, effective March 25. Since joining Sirtex in 2023, Schmidt has been an integral part of the company's executive leadership team, collaborating with senior leaders and...

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis - Vimarsana News

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis

This clinical trial compares a paclitaxel-coated balloon vs an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary interventi

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial | Anticoagulation | JAMA - Vimarsana News

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial | Anticoagulation | JAMA

This randomized trial compares the effect of intermediate-dose vs standard prophylactic enoxaparin on a composite outcome of acute venous thromboembolism (VTE),

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance - Vimarsana News

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023,...